CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands |
Total |
Sonder Legacy Warrants |
Delayed Draw Warrants |
As Previously Reported |
Retroactive adjustment to reflect the exchange ratio due to business combination |
Redeemable Convertible Preferred Stock |
Redeemable Convertible Preferred Stock
As Previously Reported
|
Redeemable Convertible Preferred Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
|
Exchangeable Preferred Stock |
Exchangeable Preferred Stock
As Previously Reported
|
Exchangeable Preferred Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
|
Post-Combination Exchangeable Common Stock |
Common Stock
Common Stock
|
Common Stock
Common Stock
Sonder Legacy Warrants
|
Common Stock
Common Stock
As Previously Reported
|
[1] |
Common Stock
Common Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
|
[1] |
Common Stock
Exchangeable Series AA Stock
|
Common Stock
Exchangeable Series AA Stock
As Previously Reported
|
Common Stock
Exchangeable Series AA Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
|
[1] |
Common Stock
Post-Combination Exchangeable Common Stock
|
Common Stock
Post-Combination Exchangeable Common Stock
As Previously Reported
|
Additional Paid-in Capital |
[1] |
Additional Paid-in Capital
Sonder Legacy Warrants
|
[1] |
Additional Paid-in Capital
Delayed Draw Warrants
|
[1] |
Additional Paid-in Capital
As Previously Reported
|
[1] |
Accumulated Translation Adjustment |
Accumulated Translation Adjustment
As Previously Reported
|
Accumulated Deficit |
Accumulated Deficit
As Previously Reported
|
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2020 |
[1] |
|
|
|
|
|
5,556,051
|
|
3,783,233
|
|
1,772,818
|
925,669
|
630,308
|
295,361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance at Dec. 31, 2020 |
|
|
|
|
|
|
$ 517,730
|
[1] |
$ 517,730
|
[1] |
|
$ 49,733
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Mezzanine Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock (in shares) |
[1] |
|
|
|
|
|
6,819
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock |
[1] |
|
|
|
|
|
$ 1,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Exchangeable Preferred Stock to Convertible Preferred Stock (in shares) |
[1] |
|
|
|
|
|
699
|
|
|
|
|
(699)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance (As Restated) (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
|
|
5,563,569
|
|
|
|
|
924,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance at Dec. 31, 2021 |
|
|
|
|
|
|
$ 518,750
|
[1] |
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
526,474
|
[1] |
|
358,487
|
167,987
|
692,984
|
[1] |
471,868
|
[1] |
221,116
|
0
|
0
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2020 |
|
$ (504,962)
|
|
|
$ (500,860)
|
$ (4,102)
|
|
|
|
|
|
|
|
|
|
$ 0
|
[1] |
|
$ 0
|
|
$ 0
|
|
$ 0
|
|
|
$ 0
|
$ 0
|
$ 13,899
|
|
|
$ 13,899
|
$ 5,666
|
$ 5,666
|
$ (524,527)
|
$ (524,527)
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Series AA stock to common stock (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,187
|
|
|
|
|
(1,187)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
105,830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
|
3,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,841
|
|
|
|
|
|
|
|
Exercise of common stock warrants (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock warrants |
|
120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120
|
|
|
|
|
|
|
|
Stock-based compensation |
|
25,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,247
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(293,955)
|
|
|
(294,387)
|
432
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(293,955)
|
|
Change in cumulative translation adjustment |
|
1,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,633
|
|
|
|
Ending balance (As Restated) (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
637,608
|
[1] |
|
|
|
691,797
|
[1] |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Dec. 31, 2021 |
|
(768,076)
|
|
|
(764,406)
|
(3,670)
|
|
|
|
|
|
|
|
|
|
$ 0
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
43,107
|
|
|
|
7,299
|
|
(818,482)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
13,147
|
|
|
10,963
|
2,184
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Mar. 31, 2022 |
|
133,517
|
|
|
135,988
|
(2,471)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
|
|
5,563,569
|
|
|
|
|
924,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance at Dec. 31, 2021 |
|
|
|
|
|
|
$ 518,750
|
[1] |
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
637,608
|
[1] |
|
|
|
691,797
|
[1] |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2021 |
|
(768,076)
|
|
|
(764,406)
|
(3,670)
|
|
|
|
|
|
|
|
|
|
$ 0
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
43,107
|
|
|
|
7,299
|
|
(818,482)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(41,497)
|
|
|
(34,703)
|
(6,794)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Jun. 30, 2022 |
|
89,162
|
|
|
101,092
|
(11,930)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
|
|
5,563,569
|
|
|
|
|
924,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance at Dec. 31, 2021 |
|
|
|
|
|
|
$ 518,750
|
[1] |
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
637,608
|
[1] |
|
|
|
691,797
|
[1] |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2021 |
|
(768,076)
|
|
|
(764,406)
|
(3,670)
|
|
|
|
|
|
|
|
|
|
$ 0
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
43,107
|
|
|
|
7,299
|
|
(818,482)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(114,618)
|
|
|
(108,392)
|
(6,226)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Sep. 30, 2022 |
|
26,635
|
|
|
38,771
|
(12,136)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 |
[1] |
|
|
|
|
|
5,563,569
|
|
|
|
|
924,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance at Dec. 31, 2021 |
|
|
|
|
|
|
$ 518,750
|
[1] |
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Mezzanine Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock (in shares) |
[1] |
|
|
|
|
|
(5,563,569)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock |
[1] |
|
|
|
|
|
$ (518,750)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
(924,970)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination |
|
|
|
|
|
|
|
|
|
|
|
$ (49,733)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
637,608
|
[1] |
|
|
|
691,797
|
[1] |
|
|
|
0
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2021 |
|
(768,076)
|
|
|
(764,406)
|
(3,670)
|
|
|
|
|
|
|
|
|
|
$ 0
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
43,107
|
|
|
|
7,299
|
|
(818,482)
|
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants from liabilities to equity |
|
2,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,111
|
|
|
|
|
|
|
|
CEO promissory note settlement (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(136,281)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,761
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants |
|
|
$ 1,243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,243
|
|
|
|
|
|
|
Conversion of convertible note (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
950,855
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible note |
|
159,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
159,173
|
|
|
|
|
|
|
|
Conversion of preferred stock (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,563,569
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock |
|
$ 518,761
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
|
|
|
|
|
|
|
518,760
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
|
46,568
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,568
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
|
$ 1,620
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,620
|
|
|
|
|
|
|
|
Issuance of common stock in connection with the business combination and PIPE offering (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,192,291
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock in connection with the business combination and PIPE offering |
|
267,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
267,362
|
|
|
|
|
|
|
|
Assumption of SPAC Warrants upon consummation of business combination |
|
(25,985)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,985)
|
|
|
|
|
|
|
|
Earn Out Liability recognized upon consummation of business combination |
|
(98,117)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(98,117)
|
|
|
|
|
|
|
|
Issuance of Delayed Draw Warrants |
|
|
|
$ 5,598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,598
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(691,797)
|
[1] |
|
|
|
1,616,767
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination |
|
49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,733
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
|
58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58
|
|
|
|
|
|
|
|
Conversion of exchangeable stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
597,307
|
[1] |
|
|
|
|
|
|
|
|
(597,307)
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock |
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
Stock-based compensation |
|
24,337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,337
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(245,031)
|
|
|
(165,742)
|
(79,289)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(245,031)
|
|
Change in cumulative translation adjustment |
|
5,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,727
|
|
|
|
Ending balance (As Restated) (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,019,460
|
9,919,716
|
[1] |
|
|
|
0
|
[1] |
|
|
|
1,019,460
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Dec. 31, 2022 |
|
(101,485)
|
|
|
(19,947)
|
(81,538)
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
949,001
|
|
|
|
13,026
|
|
(1,063,513)
|
|
Beginning balance (As Restated) at Mar. 31, 2022 |
|
133,517
|
|
|
135,988
|
(2,471)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(54,644)
|
|
|
(45,666)
|
(8,978)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Jun. 30, 2022 |
|
89,162
|
|
|
101,092
|
(11,930)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(73,121)
|
|
|
(73,689)
|
568
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Sep. 30, 2022 |
|
26,635
|
|
|
38,771
|
(12,136)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2022 |
|
(101,485)
|
|
|
(19,947)
|
(81,538)
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
949,001
|
|
|
|
13,026
|
|
(1,063,513)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(81,865)
|
|
|
(86,431)
|
4,566
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Mar. 31, 2023 |
|
(175,955)
|
|
|
(96,827)
|
(79,128)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,019,460
|
9,919,716
|
[1] |
|
|
|
0
|
[1] |
|
|
|
1,019,460
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2022 |
|
(101,485)
|
|
|
(19,947)
|
(81,538)
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
949,001
|
|
|
|
13,026
|
|
(1,063,513)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(126,049)
|
|
|
(131,758)
|
5,709
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Jun. 30, 2023 |
|
(215,262)
|
|
|
(136,592)
|
(78,670)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,019,460
|
9,919,716
|
[1] |
|
|
|
0
|
[1] |
|
|
|
1,019,460
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2022 |
|
(101,485)
|
|
|
(19,947)
|
(81,538)
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
949,001
|
|
|
|
13,026
|
|
(1,063,513)
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(183,679)
|
|
|
(196,034)
|
12,355
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Sep. 30, 2023 |
|
(264,421)
|
|
|
(192,688)
|
(71,733)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,019,460
|
9,919,716
|
[1] |
|
|
|
0
|
[1] |
|
|
|
1,019,460
|
|
|
|
|
|
|
|
|
|
Beginning balance (As Restated) at Dec. 31, 2022 |
|
$ (101,485)
|
|
|
(19,947)
|
(81,538)
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
949,001
|
|
|
|
13,026
|
|
(1,063,513)
|
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
|
469
|
|
|
|
|
|
|
|
|
|
|
|
|
|
469
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
|
$ 8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,062
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
306,478
|
[1] |
|
|
|
|
|
|
|
|
(306,478)
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
28,494
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,494
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(295,668)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(295,668)
|
|
Change in cumulative translation adjustment |
|
(8,050)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,050)
|
|
|
|
Ending balance (As Restated) (in shares) at Dec. 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
712,982
|
10,380,725
|
[1] |
|
|
|
0
|
[1] |
|
|
|
712,982
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Dec. 31, 2023 |
|
(376,701)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
[1] |
|
|
|
$ 0
|
|
|
|
|
$ 0
|
|
$ 977,503
|
|
|
|
$ 4,976
|
|
$ (1,359,181)
|
|
Beginning balance (As Restated) at Mar. 31, 2023 |
|
(175,955)
|
|
|
(96,827)
|
(79,128)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(44,184)
|
|
|
(45,327)
|
1,143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Jun. 30, 2023 |
|
(215,262)
|
|
|
(136,592)
|
(78,670)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
(57,630)
|
|
|
(64,276)
|
6,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (As Restated) at Sep. 30, 2023 |
|
$ (264,421)
|
|
|
$ (192,688)
|
$ (71,733)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|